JPH08325470A - Pyrazolone compound - Google Patents

Pyrazolone compound

Info

Publication number
JPH08325470A
JPH08325470A JP7136413A JP13641395A JPH08325470A JP H08325470 A JPH08325470 A JP H08325470A JP 7136413 A JP7136413 A JP 7136413A JP 13641395 A JP13641395 A JP 13641395A JP H08325470 A JPH08325470 A JP H08325470A
Authority
JP
Japan
Prior art keywords
group
compound
added
substituted
pyrazolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7136413A
Other languages
Japanese (ja)
Inventor
Shigeru Yamazaki
茂 山崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Priority to JP7136413A priority Critical patent/JPH08325470A/en
Publication of JPH08325470A publication Critical patent/JPH08325470A/en
Pending legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)

Abstract

PURPOSE: To obtain a novel bis-1-substd.-5-pyrazolone compd. which is an intermediate for the preparation of a polymer dye and can provide a dye causing no diffusion of a photosensitive material from a hydrophilic binder layer into other layer(s). CONSTITUTION: This pyrazolone compd. is represented by the formula (wherein X represents a 1-6C methylene, phenylene, pyridin-diyl; R<1> represents H or a halogen; Y represents a 1-6C alkyl or hydroxyl group; and (n) and (m) are 1 or 2). In the formula, the 1-substd.-pyrazolone-3-yl is pref. in a meta or para position on the phenyl ring relative to the NHCO-X-CONH. In the formula, this compd. is represented as having a 5-pyrazolone ring. However, the compd. embraces also a compound having a 5-hydroxy-pyrazole ring due to tautomerism. The compd. is a novel compd. useful as an intermediate for the preparation of a polymer dye. The polymer dye prepared from this intermediate is hydrophilic and suitable for a photosensitive material.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、ピラゾロン化合物に関
するものである。さらに具体的には、本発明は、ポリマ
ー系染料製造のための製造中間体などに有用な新規ピラ
ゾロン化合物に関する。
FIELD OF THE INVENTION The present invention relates to a pyrazolone compound. More specifically, the present invention relates to a novel pyrazolone compound useful as a production intermediate for the production of polymer dyes.

【0002】[0002]

【従来の技術】1-置換−5-ヒドロキシ−ピラゾール類
は、細田豊著「理論・製造 染料化学」(技報堂発行
1957年刊)に記載されているように、染料の中間体とし
て有用な化合物である。また、1-置換−5-ヒドロキシ−
ピラゾール類を製造中間体とする染料は、ハロゲン化銀
写真感光材料に添加する染料として有用であり、分光感
度を調節したり、イラジエーションやハレーションを防
止する作用を有していることが知られている。具体的に
は、米国特許2274782 号明細書、特開昭51-77327号公
報、特開昭54-118247 号公報、特開平3-288841号公報、
及び、特公平4-8466号公報等に記載された染料が見いだ
されている。しかしながら、これらのピラゾール類を中
間体とする染料を感光材料のゼラチン等の親水性バイン
ダー層に含有させると、容易に他層に拡散してしまうと
いう問題があった。
2. Description of the Related Art 1-Substituted-5-hydroxy-pyrazoles are described in "Theory and Manufacturing Dye Chemistry" by Yutaka Hosoda (published by Gihodo.
1957), it is a compound useful as an intermediate for dyes. Also, 1-substituted-5-hydroxy-
Dyes containing pyrazoles as a production intermediate are useful as dyes added to silver halide photographic light-sensitive materials, and are known to have a function of controlling spectral sensitivity and preventing irradiation and halation. ing. Specifically, U.S. Pat.No. 2,274,782, JP-A-51-77327, JP-A-54-118247, JP-A-3-288841,
Also, the dyes described in Japanese Examined Patent Publication No. 4-8466 are found. However, when a dye having these pyrazoles as an intermediate is contained in a hydrophilic binder layer such as gelatin of a light-sensitive material, there is a problem that the dye easily diffuses to another layer.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は、感光
材料などの親水性バインダー層に含有させた場合にも他
層に拡散することがない染料を製造するために有用な製
造中間体として、新規な1-置換−5-ヒドロキシ−ピラゾ
ール類を提供することにある。
The object of the present invention is to provide a useful intermediate for producing a dye which does not diffuse into other layers when incorporated in a hydrophilic binder layer such as a light-sensitive material. , To provide novel 1-substituted-5-hydroxy-pyrazoles.

【0004】[0004]

【課題を解決するための手段】本発明者は上記の課題を
解決すべく鋭意努力した結果、下記の一般式で示される
新規なビス−1-置換−5-ヒドロキシ−ピラゾール(ビス
−1-置換−5-ピラゾロン)化合物が、ポリマー系の染料
の製造中間体として有用であり、得られたポリマー系染
料が親水性バインダー層に含有させた場合にも他層に拡
散せず、感光材料の製造のための染料として優れた性質
を有していることを見い出した。本発明は上記の知見を
基にして完成されたものである。
As a result of diligent efforts to solve the above problems, the present inventor has developed a novel bis-1-substituted-5-hydroxy-pyrazole (bis-1- Substituted-5-pyrazolone) compounds are useful as intermediates for the production of polymer-based dyes, and even when the obtained polymer-based dyes are contained in a hydrophilic binder layer, they do not diffuse into other layers and It has been found to have excellent properties as a dye for manufacturing. The present invention has been completed based on the above findings.

【0005】すなわち本発明は、以下の式:That is, the present invention provides the following formula:

【化2】 (式中、X は炭素数 1〜6 の直鎖若しくは分岐鎖のメチ
レン基、置換若しくは無置換のフェニレン基、又は置換
若しくは無置換のピリジンジイル基を示し、R1はそれぞ
れ独立に水素原子又はハロゲン原子を示し、Y はそれぞ
れ独立に炭素数 1〜6 の直鎖若しくは分岐鎖のアルキル
基又は水酸基を示し、n 及び mはそれぞれ独立に1 又は
2 を示す)で示されるピラゾロン化合物を提供するもの
である。
Embedded image (In the formula, X represents a linear or branched methylene group having 1 to 6 carbon atoms, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted pyridinediyl group, and R 1's each independently represent a hydrogen atom or Represents a halogen atom, Y represents each independently a linear or branched alkyl group having 1 to 6 carbon atoms or a hydroxyl group, and n and m each independently represent 1 or
The present invention provides a pyrazolone compound represented by 2).

【0006】本発明の化合物は、同一または非同一の二
個の (1-置換- ピラゾロン-3- イル)-フェニル基が-NHC
O-X-CONH- 基で結合されたいわゆるビス型の化合物であ
り、好ましくは、同一の二個の (1-置換- ピラゾロン-3
- イル)-フェニル基が-NHCO-X-CONH- 基で結合された化
合物である。上記式中、X は炭素数 1〜6 の直鎖若しく
は分岐鎖のメチレン基、置換若しくは無置換のフェニレ
ン基、又は置換若しくは無置換のピリジンジイル基を示
す。メチレン基としては、例えば、-CH2-, -CH2CH2-, -
(CH2)3-, -(CH2)4-, -(CH2)5-, -(CH2)6-, -CH(CH3)CH2
-, -CH2CH(CH3)-, -CH(CH3)CH2CH2-, -CH2CH(CH3)CH2-,
-CH2CH2CH(CH3)-, -CH(CH2CH3)CH2CH2-, -CH(CH3)CH(C
H3)CH2-, 及び -CH(CH2CH3)CH(CH3)CH2- などを例示す
ることができるがこれらに限定されることはない。これ
らのうち、炭素数 3〜5 の直鎖メチレン基が好ましく、
-(CH2)4-基が特に好ましい。
The compound of the present invention has two (1-substituted-pyrazolon-3-yl) -phenyl groups which are the same or non-identical and which are —NHC.
It is a so-called bis-type compound bonded by an OX-CONH- group, and preferably two identical (1-substituted-pyrazolone-3
-Yl) -phenyl group is a compound bonded by -NHCO-X-CONH- group. In the above formula, X represents a linear or branched methylene group having 1 to 6 carbon atoms, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted pyridinediyl group. Examples of the methylene group include -CH 2- , -CH 2 CH 2 -,-
(CH 2 ) 3 -,-(CH 2 ) 4 -,-(CH 2 ) 5 -,-(CH 2 ) 6- , -CH (CH 3 ) CH 2
-, -CH 2 CH (CH 3 )-, -CH (CH 3 ) CH 2 CH 2- , -CH 2 CH (CH 3 ) CH 2- ,
-CH 2 CH 2 CH (CH 3 )-, -CH (CH 2 CH 3 ) CH 2 CH 2- , -CH (CH 3 ) CH (C
H 3 ) CH 2- , and -CH (CH 2 CH 3 ) CH (CH 3 ) CH 2- can be exemplified, but the present invention is not limited thereto. Of these, a linear methylene group having 3 to 5 carbon atoms is preferable,
- (CH 2) 4 - group is particularly preferred.

【0007】フェニレン基としては、o-フェニレン基、
m-フェニレン基、又はp-フェニレン基のいずれを用いて
もよいが、m-フェニレン基又はp-フェニレン基が好まし
い。ピリジンジイル基は、ピリジンの任意の異なる2つ
の環炭素原子から水素原子を除いて形成される2価の基
を示す。例えば、2,3-ピリジンジイル基、2,4-ピリジン
ジイル基、2,5-ピリジンジイル基、2,6-ピリジンジイル
基、3,4-ピリジンジイル基、3,5-ピリジンジイル基のい
ずれであってもよい。これらのフェニレン基またはピリ
ジンジイル基は、1または2以上の任意の置換基を有し
ていてもよい。このような置換基としては、炭素数 1〜
6 の直鎖若しくは分岐鎖のアルキル基、炭素数 1〜6 の
直鎖若しくは分岐鎖のアルコキシ基、又はハロゲン原子
などを用いることができる。
The phenylene group is an o-phenylene group,
Either an m-phenylene group or a p-phenylene group may be used, but an m-phenylene group or a p-phenylene group is preferred. The pyridinediyl group represents a divalent group formed by removing a hydrogen atom from two different ring carbon atoms of pyridine. For example, 2,3-pyridinediyl group, 2,4-pyridinediyl group, 2,5-pyridinediyl group, 2,6-pyridinediyl group, 3,4-pyridinediyl group, 3,5-pyridinediyl group Either may be used. These phenylene groups or pyridinediyl groups may have one or two or more optional substituents. Such a substituent has 1 to 10 carbon atoms.
A 6 straight-chain or branched-chain alkyl group, a straight-chain or branched-chain alkoxy group having 1 to 6 carbon atoms, or a halogen atom can be used.

【0008】炭素数 1〜6 の直鎖若しくは分岐鎖のアル
キル基としては、例えば、メチル基、エチル基、n-プロ
ピル基、イソプロピル基、n-ブチル基、sec-ブチル基、
tert- ブチル基、n-ペンチル基、ネオペンチル基、又は
n-ヘキシル基などを用いることができる。炭素数 1〜6
の直鎖若しくは分岐鎖のアルコキシ基としては、例え
ば、メトキシ基、エトキシ基、n-プロポキシ基、イソプ
ロポキシ基、n-ブトキシ基、sec-ブトキシ基、tert- ブ
トキシ基、n-ペントキシ基、ネオペントキシ基、又はn-
ヘキソキシ基などを用いることができる。ハロゲン原子
としては、フッ素原子、塩素原子、臭素原子、又はヨウ
素原子のいずれを用いてもよい。
Examples of the linear or branched alkyl group having 1 to 6 carbon atoms include methyl group, ethyl group, n-propyl group, isopropyl group, n-butyl group, sec-butyl group,
tert-butyl group, n-pentyl group, neopentyl group, or
An n-hexyl group or the like can be used. 1 to 6 carbon atoms
Examples of the linear or branched alkoxy group include, for example, methoxy group, ethoxy group, n-propoxy group, isopropoxy group, n-butoxy group, sec-butoxy group, tert-butoxy group, n-pentoxy group, neopentoxy group. Group or n-
A hexoxy group or the like can be used. As the halogen atom, any of a fluorine atom, a chlorine atom, a bromine atom or an iodine atom may be used.

【0009】上記式中、-NHCO-X-CONH- 基が結合するフ
ェニル基上に置換する1-置換−ピラゾロン-3- イル基
は、フェニル環上の任意の位置に置換していてもよい
が、該フェニル環上で-NHCO-X-CONH- 基に対してm-また
はp-置換となることが好ましく、p-置換となることが特
に好ましい。R1は独立に水素原子またはハロゲン原子を
示すが、ハロゲン原子としては、フッ素原子、塩素原
子、臭素原子、又はヨウ素原子のいずれであってもよ
い。これらのうち、R1が水素原子または塩素原子である
ことが好ましい。また、Y は独立に水酸基または炭素数
1〜6 の直鎖若しくは分岐鎖のアルキル基を示す。Y が
水酸基を示す場合には、-SO2Y はスルホン酸基を示す。
炭素数 1〜6 の直鎖若しくは分岐鎖のアルキル基として
は上記に例示したものを用いることができるが、メチル
基又はエチル基であることが好ましい。
In the above formula, the 1-substituted-pyrazolon-3-yl group substituted on the phenyl group to which the -NHCO-X-CONH- group is bonded may be substituted at any position on the phenyl ring. Is preferably m- or p-substituted with respect to the -NHCO-X-CONH- group on the phenyl ring, and particularly preferably p-substituted. R 1 independently represents a hydrogen atom or a halogen atom, and the halogen atom may be any of a fluorine atom, a chlorine atom, a bromine atom or an iodine atom. Of these, R 1 is preferably a hydrogen atom or a chlorine atom. Y is independently hydroxyl group or carbon number
1 to 6 represents a linear or branched alkyl group. When Y 2 represents a hydroxyl group, —SO 2 Y represents a sulfonic acid group.
As the linear or branched alkyl group having 1 to 6 carbon atoms, those exemplified above can be used, but a methyl group or an ethyl group is preferable.

【0010】n 及びm は独立に1又は2を示すが、これ
らが1の場合には、ピラゾロンの1-位に置換するフェニ
ル基上に -SO2Yで示される基が1個置換していることを
示し、2の場合には、ピラゾロンの1-位に置換するフェ
ニル基上に -SO2Yで示される基が2個置換していること
を示す。ピラゾロンの1-位に置換するフェニル基上のR1
及び1又は2個の -SO2Yは、それぞれフェニル環上の任
意の位置に置換していてもよい。
N and m each independently represent 1 or 2, but when these are 1, a group represented by --SO 2 Y is substituted on the phenyl group substituted at the 1-position of pyrazolone. In the case of 2, it means that two groups represented by -SO 2 Y are substituted on the phenyl group substituted at the 1-position of pyrazolone. R 1 on the phenyl group substituting the 1-position of pyrazolone
And each of 1 or 2 —SO 2 Y may be substituted at any position on the phenyl ring.

【0011】本発明の化合物は、酸付加塩若しくは塩基
付加塩として存在することがあり、遊離形態の化合物若
しくは上記の塩は水和物若しくは溶媒和物として存在す
る場合があるが、これらはいずれも本発明の範囲に包含
される。酸付加塩としては、例えば、塩酸塩、硫酸塩、
臭化水素酸塩、沃化水素酸塩、硝酸塩などの鉱酸塩や、
パラトルエンスルホン酸塩、メタンスルホン酸塩、カン
ファースルホン酸塩、酒石酸塩、クエン酸塩などの有機
酸塩を挙げることができる。塩基付加塩としては、ナト
リウム塩、カリウム塩、マグネシウム塩、カルシウム塩
等の金属塩やアンモニウム塩のほか、メチルアミン塩、
ジメチルアミン塩、トリエチルアミン塩などの有機アミ
ン塩を挙げることができる。
The compound of the present invention may exist as an acid addition salt or a base addition salt, and the compound in the free form or the above salt may exist as a hydrate or a solvate. Also included within the scope of the invention. As the acid addition salt, for example, hydrochloride, sulfate,
Mineral salts such as hydrobromide, hydroiodide and nitrate,
Organic acid salts such as paratoluene sulfonate, methane sulfonate, camphor sulfonate, tartrate and citrate may be mentioned. Examples of the base addition salt include metal salts such as sodium salt, potassium salt, magnesium salt, calcium salt and ammonium salt, methylamine salt,
Examples thereof include organic amine salts such as dimethylamine salt and triethylamine salt.

【0012】本発明の化合物は、置換基の種類により、
1または2個以上の不斉炭素を有する場合があるが、こ
のような1または2個以上の不斉炭素に基づく任意の光
学異性体、または2個以上の不斉炭素に基づく任意のジ
アステレオ異性体はすべて本発明の範囲に包含される。
また、上記の光学異性体若しくはジアステレオ異性体の
純粋な形態の異性体、任意の混合物、ラセミ体なども全
て本発明の範囲に包含される。さらに、本発明の化合物
は5-ピラゾロン骨格を部分構造として含んでいるが、5-
ピラゾロン環は互変異性により5-ヒドロキシ−ピラゾー
ル環として存在する場合があることは当業者に自明であ
る。上記一般式は、便宜上、5-ピラゾロン環を有する化
合物について説明したが、物理化学的性質が同一である
か否かにかかわらず、これらの互変異性体はいずれも本
発明の範囲に包含されることは言うまでもない。
The compound of the present invention is, depending on the kind of the substituent,
It may have one or more asymmetric carbons, but any optical isomer based on such one or more asymmetric carbons, or any diastereomer based on two or more asymmetric carbons All isomers are included within the scope of the invention.
Further, all the isomers in the pure form of the above optical isomers or diastereoisomers, arbitrary mixtures, racemates and the like are also included in the scope of the present invention. Furthermore, although the compound of the present invention contains the 5-pyrazolone skeleton as a partial structure,
It will be apparent to those skilled in the art that the pyrazolone ring may exist as a 5-hydroxy-pyrazole ring due to tautomerism. Although the above general formula has been described for a compound having a 5-pyrazolone ring for the sake of convenience, all of these tautomers are included in the scope of the present invention regardless of whether or not they have the same physicochemical properties. Needless to say.

【0013】本発明の好ましい化合物としては、例え
ば、 (a) X が炭素数 3〜5 の直鎖メチレン基、無置換のフェ
ニレン基、又は無置換のピリジンジイル基であり;R1
独立に水素原子又はハロゲン原子であり;Y が水酸基で
あり;かつ、n 及び mがそれぞれ独立に1 又は2 である
化合物; (b) X が-(CH2)4-、無置換のm-若しくはp-フェニレン
基、又は無置換の2,6-ピリジンジイル基であり;-NHCO-
X-CONH- 基が結合するフェニル基上に置換するピラゾロ
ン-3- イル基が該フェニル環上で-NHCO-X-CONH- 基に対
してm-またはp-置換であり;R1が独立に水素原子又は塩
素原子であり;Y が水酸基であり;かつ、n及び mがそ
れぞれ独立に1 又は2 である化合物;及び (c) 上記の(b) 群の化合物において、ピラゾロン-3- イ
ル基が該フェニル環上で-NHCO-X-CONH- 基に対してp-置
換である化合物を挙げることができる。
Preferred compounds of the present invention include, for example, (a) X is a linear methylene group having 3 to 5 carbon atoms, an unsubstituted phenylene group, or an unsubstituted pyridinediyl group; R 1 is independently a hydrogen atom or a halogen atom; Y is a hydroxyl group; and compounds wherein n and m are each independently 1 or 2; (b) X is - (CH 2) 4 -, unsubstituted m- or p -A phenylene group or an unsubstituted 2,6-pyridinediyl group; -NHCO-
A pyrazolon-3-yl group substituted on the phenyl group to which the X-CONH- group is bonded is m- or p-substituted on the phenyl ring with respect to the -NHCO-X-CONH- group; R 1 is independent Is a hydrogen atom or a chlorine atom; Y is a hydroxyl group; and n and m are each independently 1 or 2, and (c) in the compound of the above (b) group, pyrazolone-3-yl Mention may be made of compounds in which the group is p-substituted on the phenyl ring with respect to the -NHCO-X-CONH- group.

【0014】上記の(C) 群に包含される化合物のうち好
ましい化合物を以下の表1に例示するが、本発明の範囲
はこれらに限定されることはない(表中、化合物番号を
付した化合物は実施例中に製造例を記載した化合物であ
る)。なお、以下の表中、「スルホ」と記載したものに
ついては、遊離形態または塩の形態のスルホン酸基を示
し、「ジスルホ」と記載したものについては、2個のス
ルホン酸基が、共に遊離形態であるもの、1のスルホン
酸基が遊離形態であり他のスルホン酸基が塩の形態であ
るもの、及び2個のスルホン酸基が共に同一または異な
る塩基付加塩の形態であるものを含む。
Preferred compounds among the compounds included in the above-mentioned group (C) are illustrated in Table 1 below, but the scope of the present invention is not limited thereto (in the table, compound numbers are added. The compound is the compound described in Preparation Examples in Examples). In the table below, “sulfo” indicates a sulfonic acid group in a free form or salt form, and “disulfo” indicates that two sulfonic acid groups are both released. Forms, including one sulfonic acid group in free form and the other sulfonic acid group in salt form, and two sulfonic acid groups both in the same or different base addition salt form .

【表1】 ───────────────────────────── X R1 -(SO3H)n ───────────────────────────── -(CH2)4- -H 4-スルホ (化合物8) 〃 -H 3-スルホ 〃 -H 2-スルホ 〃 -H 2,5-ジスルホ(化合物9) 〃 -H 2,4-ジスルホ 〃 4-Cl 3-スルホ (化合物2) 〃 3-Cl 4-スルホ 〃 2-Cl 4-スルホ 〃 2-Cl 3-スルホ 〃 2-Cl 5-スルホ 〃 4-Cl 2,5-ジスルホ 〃 3-Cl 2,5-ジスルホ m-フェニレン基 -H 4-スルホ (化合物5) 〃 -H 3-スルホ 〃 -H 2-スルホ 〃 -H 2,5-ジスルホ(化合物6) 〃 -H 2,4-ジスルホ 〃 4-Cl 3-スルホ 〃 3-Cl 4-スルホ 〃 2-Cl 4-スルホ 〃 2-Cl 3-スルホ 〃 2-Cl 5-スルホ 〃 4-Cl 2,5-ジスルホ 〃 3-Cl 2,5-ジスルホ p-フェニレン基 -H 4-スルホ (化合物3) 〃 -H 3-スルホ 〃 -H 2-スルホ 〃 -H 2,5-ジスルホ(化合物4) 〃 -H 2,4-ジスルホ 〃 4-Cl 3-スルホ (化合物1) 〃 3-Cl 4-スルホ 〃 2-Cl 4-スルホ 〃 2-Cl 3-スルホ 〃 2-Cl 5-スルホ 〃 4-Cl 2,5-ジスルホ 〃 3-Cl 2,5-ジスルホ 2,6-ピリジンジイル基 -H 4-スルホ 〃 -H 3-スルホ 〃 -H 2-スルホ 〃 -H 2,5-ジスルホ(化合物7) 〃 -H 2,4-ジスルホ 〃 4-Cl 3-スルホ 〃 3-Cl 4-スルホ 〃 2-Cl 4-スルホ 〃 2-Cl 3-スルホ 〃 2-Cl 5-スルホ 〃 4-Cl 2,5-ジスルホ 〃 3-Cl 2,5-ジスルホ ────────────────────────────[Table 1] ───────────────────────────── XR 1- (SO 3 H) n ───────── ─────────────────────-(CH 2 ) 4 --H 4-sulfo (Compound 8) 〃 -H 3-sulfo 〃 -H 2-sulfo 〃 -H 2,5-disulfo (compound 9) 〃 -H 2,4-disulfo 〃 4-Cl 3-sulfo (compound 2) 〃 3-Cl 4-sulfo 〃 2-Cl 4-sulfo 〃 2-Cl 3- Sulfo 〃 2-Cl 5-sulfo 〃 4-Cl 2,5-disulfo 〃 3-Cl 2,5-disulfo m-phenylene group -H 4-sulfo (Compound 5) 〃 -H 3-sulfo 〃 -H 2- Sulfo 〃 -H 2,5-disulfo (compound 6) 〃 -H 2,4-disulfo 〃 4-Cl 3-sulfo 〃 3-Cl 4-sulfo 〃 2-Cl 4-sulfo 〃 2-Cl 3-sulfo 〃 2-Cl 5-sulfo 〃 4-Cl 2,5-disulfo 〃 3-Cl 2,5-disulfo p-phenylene group -H 4-sulfo (Compound 3) 〃 -H 3-sulfo 〃 -H 2-sulfo 〃 -H 2,5-disulfo (Compound 4) 〃 -H 2,4-dis White 4-Cl 3-Sulfo (Compound 1) White 3-Cl 4-Sulfo 2-Cl 4-Sulfo 2-Cl 3-Sulfo 2-Cl 5-Sulfo 4-Cl 2,5-Disulfo 〃 3-Cl 2,5-disulfo 2,6-pyridinediyl group -H 4-sulfo 〃 -H 3-sulfo 〃 -H 2-sulfo 〃 -H 2,5-disulfo (Compound 7) 〃 -H 2,4 -Disulfo 〃 4-Cl 3-Sulfo 〃 3-Cl 4-Sulfo 〃 2-Cl 4-Sulfo 〃 2-Cl 3-Sulfo 〃 2-Cl 5-Sulfo 〃 4-Cl 2,5-Disulfo 〃 3-Cl 2,5-Disulfo ────────────────────────────

【0015】本発明の化合物の製造方法は、上記の表1
に示される化合物のうちの代表的な化合物について実施
例中に詳細に説明されている。実施例の製造方法に従っ
た本発明の製造方法の一例を、以下のスキームに示す
(スキーム中の化合物の番号は、本発明の化合物 1〜9
については上記の表1及び実施例番号、反応試薬及び原
料については実施例中に記載した化合物番号に対応して
おり、スキーム中の ArはR1及びスルホン酸基が置換し
たフェニル基を示す)。当業者はこれらの実施例を参照
することにより、あるいは、使用する原料化合物、反応
試薬、及び反応条件などを適宜改変又は修飾することに
より、上記一般式に包含される化合物を容易に製造する
ことができる。
The process for preparing the compounds of the present invention is described in Table 1 above.
Representative compounds of the compounds shown in are described in detail in the Examples. An example of the production method of the present invention according to the production method of the example is shown in the following scheme (the compound numbers in the scheme are the compounds 1 to 9 of the present invention).
(Corresponding to the compound numbers described in Examples in Table 1 and Example numbers above, and reaction reagents and starting materials, Ar in the scheme represents R 1 and a phenyl group substituted with a sulfonic acid group) . Those skilled in the art can easily produce the compounds included in the above general formula by referring to these Examples or by appropriately modifying or modifying the starting compounds, reaction reagents, reaction conditions, etc. used. You can

【0016】ピラゾロン環を含む部分構造の構築方法と
しては、対応するフェニルヒドラジン誘導体とβ−ケト
酸エステルとの縮合閉環反応 ("The Chemistry of Hete
rocyclic Compounds”ed. A. Weissberger, Vol.20, P.
9.(1964)を参照) を挙げることができる。なお、本発
明の化合物の製造方法はこれらに限定されず、いかなる
方法により製造した化合物も本発明の範囲に包含され
る。
As a method for constructing a partial structure containing a pyrazolone ring, a condensation ring-closing reaction between a corresponding phenylhydrazine derivative and a β-keto acid ester ("The Chemistry of Hete
rocyclic Compounds ”ed. A. Weissberger, Vol.20, P.
9. (see 1964)). The method for producing the compound of the present invention is not limited to these, and compounds produced by any method are included in the scope of the present invention.

【0017】[0017]

【化3】 Embedded image

【0018】本発明の化合物は、ピラゾール類を製造中
間体として得られる染料については従来知られていなか
ったポリマー系の染料の製造中間体などに有用である。
本発明の化合物を製造中間体として製造されるポリマー
染料は親水性であり、従来の疎水性ポリマー染料に比べ
て、親水性バインダー(例えばゼラチンなど)との相溶
性がよく、例えば、ハロゲン化銀写真感光材料などに含
有させた場合に他層に拡散せず、感光材料の製品安定性
を高めることが可能である。なお、ポリマー染料への変
換方法としては、例えば、特開平4-130429号公報、特開
平3-288841号公報、及び米国特許第2274782 号明細書な
どに記載された方法を採用することができる。
The compound of the present invention is useful as an intermediate for the production of polymer-based dyes, which has not hitherto been known for the dye obtained by using pyrazoles as an intermediate for production.
The polymer dye produced by using the compound of the present invention as a production intermediate is hydrophilic and has better compatibility with a hydrophilic binder (eg gelatin) than conventional hydrophobic polymer dyes. When incorporated in a photographic light-sensitive material, it does not diffuse into other layers, and it is possible to enhance the product stability of the light-sensitive material. As a method for converting into a polymer dye, for example, the methods described in JP-A No. 4-130429, JP-A No. 3-288841, US Pat. No. 2,274,782 and the like can be adopted.

【0019】[0019]

【実施例】以下、本発明を実施例によりさらに具体的に
説明するが、本発明の範囲は下記の実施例に限定される
ことはない。本実施例中に言及される化合物の構造は、
以下のとおりである。
The present invention will be described in more detail with reference to the following examples, but the scope of the present invention is not limited to the following examples. The structures of the compounds referred to in this example are:
It is as follows.

【化4】 [Chemical 4]

【0020】例1(化合物11の合成) 窒素気流下、鉄(23.7 g)、塩化アンモニウム(2.4 g) 、
水(24 ml) のイソプロピルアルコール(170 ml)溶液を 1
5 分間加熱還流した。4-ニトロベンゾイル酢酸エチル(1
0)(23.7 g)を添加してさらに 40 分加熱還流した。反応
溶液をセライト濾過し、母液から析出した結晶を濾取し
て化合物(11)(21.3 g, 90%) を得た。 例2(化合物13の合成) 化合物(2)(8.28 g) のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、テレフタロイルクロライド(12)
(4.06 g)を添加して1時間攪拌した。一規定塩酸(100 m
l)を加えて析出した結晶を濾取した。得られた結晶を水
で洗い乾燥して化合物(13)(10.8 g, 99%) を得た。
Example 1 (Synthesis of Compound 11) Under a nitrogen stream, iron (23.7 g), ammonium chloride (2.4 g),
1 solution of water (24 ml) in isopropyl alcohol (170 ml)
Heated to reflux for 5 minutes. 4-Nitrobenzoyl ethyl acetate (1
0) (23.7 g) was added, and the mixture was heated under reflux for 40 min. The reaction solution was filtered through Celite, and the crystals precipitated from the mother liquor were collected by filtration to obtain the compound (11) (21.3 g, 90%). Example 2 (Synthesis of Compound 13) Pyridine (4 ml) was added to a solution of compound (2) (8.28 g) in acetonitrile (100 ml) to prepare terephthaloyl chloride (12).
(4.06 g) was added and stirred for 1 hour. 1N hydrochloric acid (100 m
l) was added and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (13) (10.8 g, 99%).

【0021】例3(化合物15の合成) 化合物(2)(8.28 g) のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、イソフタロイルクロライド(14)
(4.06 g)を添加して1時間攪拌した。一規定塩酸(100 m
l)を加えて析出した結晶を濾取した。得られた結晶を水
で洗い乾燥して化合物(15)(10.2 g, 94%) を得た。 例4(化合物17の合成) 化合物(2)(8.28 g) のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、2,6-ピリジンジカルボニルジクロ
ライド(16)(4.08 g)を添加して1時間攪拌した。一規定
塩酸(100 ml)を加えて析出した結晶を濾取した。得られ
た結晶を水で洗い乾燥して化合物(17)(10.0 g, 92%) を
得た。
Example 3 (Synthesis of compound 15) Pyridine (4 ml) was added to a solution of compound (2) (8.28 g) in acetonitrile (100 ml) to prepare isophthaloyl chloride (14).
(4.06 g) was added and stirred for 1 hour. 1N hydrochloric acid (100 m
l) was added and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (15) (10.2 g, 94%). Example 4 (Synthesis of Compound 17) Pyridine (4 ml) was added to a solution of compound (2) (8.28 g) in acetonitrile (100 ml), and 2,6-pyridinedicarbonyldichloride (16) (4.08 g) was added. And stirred for 1 hour. 1N Hydrochloric acid (100 ml) was added and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (17) (10.0 g, 92%).

【0022】例5(化合物19の合成) 化合物(2)(8.28 g) のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、アジピン酸クロライド(18)(3.66
g)を添加して1時間攪拌した。一規定塩酸(100 ml) を
加えて析出した結晶を濾取した。得られた結晶を水で洗
い乾燥して化合物(19)(9.9 g, 78%)を得た。
Example 5 (Synthesis of Compound 19) Pyridine (4 ml) was added to a solution of compound (2) (8.28 g) in acetonitrile (100 ml), and adipic acid chloride (18) (3.66) was added.
g) was added and stirred for 1 hour. 1N hydrochloric acid (100 ml) was added, and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (19) (9.9 g, 78%).

【0023】例6(化合物1の合成) 化合物(13)(3.15 g)およびフェニルヒドラジン化合物(2
0)(3.10 g)をN,N-ジメチルアセトアミド(DMAc: 30 ml)
中に加えて3時間加熱還流した。溶媒を溜去し、残査に
イソプロピルアルコール(80 ml) を加えて析出した結晶
を濾取した。得られた結晶をイソプロピルアルコールで
洗浄して化合物(1) (5.27 g, 38%, m.p.>300 ℃) を得
た。NMR(δ ppm, CDCl3) 2.55(4H,d), 7.88(6H,m), 7.7
9(4H,s), 8.13(8H,s), 10.50(2H,s), 10.72(2H,s)
Example 6 (Synthesis of Compound 1) Compound (13) (3.15 g) and phenylhydrazine compound (2
0) (3.10 g) to N, N-dimethylacetamide (DMAc: 30 ml)
It was heated to reflux for 3 hours. The solvent was distilled off, isopropyl alcohol (80 ml) was added to the residue, and the precipitated crystals were collected by filtration. The obtained crystals were washed with isopropyl alcohol to give compound (1) (5.27 g, 38%, mp> 300 ° C). NMR (δ ppm, CDCl 3 ) 2.55 (4H, d), 7.88 (6H, m), 7.7
9 (4H, s), 8.13 (8H, s), 10.50 (2H, s), 10.72 (2H, s)

【0024】例7(化合物2の合成) 化合物(19)(1.05 g)およびフェニルヒドラジン化合物(2
0)(1.03 g)をN,N-ジメチルアセトアミド(10 ml) 中に加
えて3時間加熱還流した。溶媒を溜去し、残査にイソプ
ロピルアルコール(50 ml) を加えて析出した結晶を濾取
した。得られた結晶をイソプロピルアルコールで洗浄し
て化合物(2) (0.27 g, 16%, m.p.>300℃) を得た。NMR
(δ ppm, CDCl3) 2.57(4H,s), 7.49(2H,d), 7.67(2H,
d), 7.76(8H,d), 8.40(2H,s), 10.00(2H,s)
Example 7 (Synthesis of Compound 2) Compound (19) (1.05 g) and phenylhydrazine compound (2
0) (1.03 g) was added to N, N-dimethylacetamide (10 ml) and the mixture was heated under reflux for 3 hours. The solvent was distilled off, isopropyl alcohol (50 ml) was added to the residue, and the precipitated crystals were collected by filtration. The obtained crystals were washed with isopropyl alcohol to obtain compound (2) (0.27 g, 16%, mp> 300 ° C). NMR
(δ ppm, CDCl 3 ) 2.57 (4H, s), 7.49 (2H, d), 7.67 (2H,
d), 7.76 (8H, d), 8.40 (2H, s), 10.00 (2H, s)

【0025】例8(化合物3の合成) 化合物(13)(1.09 g)およびフェニルヒドラジン化合物(2
1)(0.76 g)をN,N-ジメチルアセトアミド(10 ml) 中に加
えて2時間加熱還流した。溶媒を溜去し、残査にイソプ
ロピルアルコール(50ml)を加えて析出した結晶を濾取し
た。得られた結晶をイソプロピルアルコールで洗浄して
化合物(3) (0.18 g, 10%, m.p.>300 ℃) を得た。NMR
(δ ppm, CDCl3) 2.55(4H,s), 7.90(4H,m), 8.04(8H,
s), 8.18(8H,s), 10.75(2H,s)
Example 8 (Synthesis of Compound 3) Compound (13) (1.09 g) and phenylhydrazine compound (2
1) (0.76 g) was added to N, N-dimethylacetamide (10 ml), and the mixture was heated under reflux for 2 hours. The solvent was distilled off, isopropyl alcohol (50 ml) was added to the residue, and the precipitated crystals were collected by filtration. The obtained crystals were washed with isopropyl alcohol to give compound (3) (0.18 g, 10%, mp> 300 ° C). NMR
(δ ppm, CDCl 3 ) 2.55 (4H, s), 7.90 (4H, m), 8.04 (8H,
s), 8.18 (8H, s), 10.75 (2H, s)

【0026】例9(化合物4の合成) 化合物(13)(1.09 g)およびフェニルヒドラジン化合物(2
2)(1.10 g)をN,N-ジメチルアセトアミド(10 ml) 中に加
えて2時間加熱還流した。析出した結晶を濾取しイソプ
ロピルアルコールで洗浄して化合物(4) (0.50 g, 26%,
m.p.>300 ℃)を得た。NMR(δ ppm, CDCl3) 2.56(4H,
d), 7.85(4H,m), 7.99(8H,s), 8.10(2H,br), 8.13(8H,
s), 10.72(2H,s)
Example 9 (Synthesis of Compound 4) Compound (13) (1.09 g) and phenylhydrazine compound (2
2) (1.10 g) was added to N, N-dimethylacetamide (10 ml), and the mixture was heated under reflux for 2 hours. The precipitated crystals were collected by filtration and washed with isopropyl alcohol to give compound (4) (0.50 g, 26%,
mp> 300 ° C.). NMR (δ ppm, CDCl 3 ) 2.56 (4H,
d), 7.85 (4H, m), 7.99 (8H, s), 8.10 (2H, br), 8.13 (8H,
s), 10.72 (2H, s)

【0027】例10(化合物5の合成) 化合物(15)(1.09 g)およびフェニルヒドラジン化合物(2
0)(0.75 g)をN,N-ジメチルアセトアミド(10 ml) 中に加
えて2時間加熱還流した。溶媒を溜去し、残査にイソプ
ロピルアルコール(50 ml) を加えて析出した結晶を濾取
した。得られた結晶をイソプロピルアルコールで洗浄し
て化合物(5) (0.26 g, 16%, m.p.>300℃) を得た。NMR
(δ ppm, CDCl3) 2.56(4H,d), 7.72(5H,m), 7.86(12H,
m), 8.18(2H,d), 8.59(1H,s), 10.54(2H,s)
Example 10 (Synthesis of Compound 5) Compound (15) (1.09 g) and phenylhydrazine compound (2
0) (0.75 g) was added to N, N-dimethylacetamide (10 ml) and the mixture was heated under reflux for 2 hours. The solvent was distilled off, isopropyl alcohol (50 ml) was added to the residue, and the precipitated crystals were collected by filtration. The obtained crystals were washed with isopropyl alcohol to give compound (5) (0.26 g, 16%, mp> 300 ° C). NMR
(δ ppm, CDCl 3 ) 2.56 (4H, d), 7.72 (5H, m), 7.86 (12H,
m), 8.18 (2H, d), 8.59 (1H, s), 10.54 (2H, s)

【0028】例11(化合物6の合成) 化合物(15)(1.09 g)およびフェニルヒドラジン化合物(2
2)(1.10 g)をN,N-ジメチルアセトアミド(10ml)中に加え
て2時間加熱還流した。溶媒を溜去し、残査にイソプロ
ピルアルコール(50ml)を加えて析出した結晶を濾取し
た。得られた結晶をイソプロピルアルコールで洗浄して
化合物(6) (0.22 g, 12%, m.p.>300 ℃)を得た。NMR
(δ ppm, CDCl3) 2.55(4H,d), 7.75(5H,m), 7.99(8H,
s), 8.17(4H,m), 8.59(1H,s), 10.58(2H,br), 10.75(2
H,s)
Example 11 (Synthesis of Compound 6) Compound (15) (1.09 g) and phenylhydrazine compound (2
2) (1.10 g) was added to N, N-dimethylacetamide (10 ml) and the mixture was heated under reflux for 2 hours. The solvent was distilled off, isopropyl alcohol (50 ml) was added to the residue, and the precipitated crystals were collected by filtration. The obtained crystals were washed with isopropyl alcohol to obtain compound (6) (0.22 g, 12%, mp> 300 ° C). NMR
(δ ppm, CDCl 3 ) 2.55 (4H, d), 7.75 (5H, m), 7.99 (8H,
s), 8.17 (4H, m), 8.59 (1H, s), 10.58 (2H, br), 10.75 (2
H, s)

【0029】例12(化合物7の合成) 化合物(17)(1.09 g)およびフェニルヒドラジン化合物(2
2)(1.10 g)をN,N-ジメチルアセトアミド(10 ml) 中に加
えて2時間加熱還流した。溶媒を溜去し、イソプロピル
アルコール(50 ml) を加えて析出した結晶を濾取した。
得られた結晶をイソプロピルアルコールで洗浄して化合
物(7) (0.19 g, 10%, m.p.>300 ℃) を得た。NMR(δ p
pm, CDCl3) 2.55(4H,d), 7.89(4H,d), 8.00(4H,d), 8.2
6(6H,br), 8.33(1H,t), 8.42(2H,d), 11.83(2H,s)
Example 12 (Synthesis of Compound 7) Compound (17) (1.09 g) and phenylhydrazine compound (2
2) (1.10 g) was added to N, N-dimethylacetamide (10 ml), and the mixture was heated under reflux for 2 hours. The solvent was distilled off, isopropyl alcohol (50 ml) was added, and the precipitated crystals were collected by filtration.
The obtained crystals were washed with isopropyl alcohol to give compound (7) (0.19 g, 10%, mp> 300 ° C). NMR (δ p
pm, CDCl 3 ) 2.55 (4H, d), 7.89 (4H, d), 8.00 (4H, d), 8.2
6 (6H, br), 8.33 (1H, t), 8.42 (2H, d), 11.83 (2H, s)

【0030】例13(化合物8の合成) 化合物(19)(1.05 g)およびフェニルヒドラジン化合物(2
1)(0.75g) をN,N-ジメチルアセトアミド(10 ml) 中に加
えて2時間加熱還流した。溶媒を溜去し、イソプロピル
アルコール(50 ml) を加えて析出した結晶を濾取した。
得られた結晶をイソプロピルアルコールで洗浄して化合
物(8) (0.24 g, 16%, m.p.>300 ℃) を得た。NMR(δ p
pm, CDCl3) 1.65(4H,br), 2.31(4H,br), 2.57(4H,d),
7.70(16H,m), 10.23(2H,s)
Example 13 (Synthesis of Compound 8) Compound (19) (1.05 g) and phenylhydrazine compound (2
1) (0.75 g) was added to N, N-dimethylacetamide (10 ml) and the mixture was heated under reflux for 2 hours. The solvent was distilled off, isopropyl alcohol (50 ml) was added, and the precipitated crystals were collected by filtration.
The obtained crystals were washed with isopropyl alcohol to give compound (8) (0.24 g, 16%, mp> 300 ° C). NMR (δ p
pm, CDCl 3 ) 1.65 (4H, br), 2.31 (4H, br), 2.57 (4H, d),
7.70 (16H, m), 10.23 (2H, s)

【0031】例14(化合物9の合成) 化合物(19)(1.05 g)およびフェニルヒドラジン化合物(2
2)(1.16 g)をN,N-ジメチルアセトアミド(10 ml) 中に加
えて2時間加熱還流した。溶媒を溜去し、イソプロピル
アルコール(50 ml) を加えて析出した結晶を濾過した。
得られた結晶をイソプロピルアルコールで洗浄して化合
物(9) (0.20g, 11%,m.p.>300 ℃) を得た。NMR(δ pp
m, CDCl3) 1.66(4H,br), 2.38(4H,br), 2.55(4H,d), 7.
63(10H,m), 7.90(2H,br), 8.14(2H,br), 10.04(2H,m),
10.25(2H,s)
Example 14 (Synthesis of Compound 9) Compound (19) (1.05 g) and phenylhydrazine compound (2
2) (1.16 g) was added to N, N-dimethylacetamide (10 ml) and the mixture was heated under reflux for 2 hours. The solvent was evaporated, isopropyl alcohol (50 ml) was added, and the precipitated crystals were filtered.
The obtained crystals were washed with isopropyl alcohol to obtain compound (9) (0.20g, 11%, mp> 300 ° C). NMR (δ pp
m, CDCl 3 ) 1.66 (4H, br), 2.38 (4H, br), 2.55 (4H, d), 7.
63 (10H, m), 7.90 (2H, br), 8.14 (2H, br), 10.04 (2H, m),
10.25 (2H, s)

【0032】[0032]

【発明の効果】本発明により、ポリマー系染料の製造中
間体などに有用な新規化合物が提供される。本発明の化
合物を製造中間体として製造されるポリマー染料は親水
性であり、感光材料の製品安定性を高めるので有用な染
料である。
INDUSTRIAL APPLICABILITY The present invention provides a novel compound useful as an intermediate for the production of polymer dyes. The polymer dyes produced using the compound of the present invention as a production intermediate are hydrophilic and are useful dyes because they enhance the product stability of the light-sensitive material.

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成8年8月30日[Submission date] August 30, 1996

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0020[Correction target item name] 0020

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0020】例1(化合物11の合成) 窒素気流下、鉄(23.7 g)、塩化アンモニウム(2.4 g) 、
水(24 ml) のイソプロピルアルコール(170 ml)溶液を 1
5 分間加熱還流した。4-ニトロベンゾイル酢酸エチル(1
0)(23.7 g)を添加してさらに 40 分加熱還流した。冷却
後、反応溶液をセライト濾過し、母液から析出した結晶
を濾取して化合物(11)(21.3 g, 90%) を得た。 例2(化合物13の合成) 化合物(11)(8.28 g)のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、テレフタロイルクロライド(12)
(4.06 g)を添加して1時間攪拌した。一規定塩酸(100 m
l)を加えて析出した結晶を濾取した。得られた結晶を水
で洗い乾燥して化合物(13)(10.8 g, 99%) を得た。
Example 1 (Synthesis of Compound 11) Under a nitrogen stream, iron (23.7 g), ammonium chloride (2.4 g),
1 solution of water (24 ml) in isopropyl alcohol (170 ml)
Heated to reflux for 5 minutes. 4-Nitrobenzoyl ethyl acetate (1
0) (23.7 g) was added, and the mixture was heated under reflux for 40 min. After cooling, the reaction solution was filtered through Celite, and the crystals precipitated from the mother liquor were collected by filtration to obtain the compound (11) (21.3 g, 90%). Example 2 (Synthesis of Compound 13) Pyridine (4 ml) was added to a solution of compound (11) (8.28 g) in acetonitrile (100 ml) to prepare terephthaloyl chloride (12).
(4.06 g) was added and stirred for 1 hour. 1N hydrochloric acid (100 m
l) was added and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (13) (10.8 g, 99%).

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0021[Correction target item name] 0021

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0021】例3(化合物15の合成) 化合物(11)(8.28 g)のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、イソフタロイルクロライド(14)
(4.06 g)を添加して1時間攪拌した。一規定塩酸(100 m
l)を加えて析出した結晶を濾取した。得られた結晶を水
で洗い乾燥して化合物(15)(10.2 g, 94%) を得た。 例4(化合物17の合成) 化合物(11)(8.28 g)のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、2,6-ピリジンジカルボニルジクロ
ライド(16)(4.08 g)を添加して1時間攪拌した。一規定
塩酸(100 ml)を加えて析出した結晶を濾取した。得られ
た結晶を水で洗い乾燥して化合物(17)(10.0 g, 92%) を
得た。
Example 3 (Synthesis of Compound 15) Pyridine (4 ml) was added to a solution of compound (11) (8.28 g) in acetonitrile (100 ml) to prepare isophthaloyl chloride (14).
(4.06 g) was added and stirred for 1 hour. 1N hydrochloric acid (100 m
l) was added and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (15) (10.2 g, 94%). Example 4 (Synthesis of Compound 17) Pyridine (4 ml) was added to a solution of compound (11) (8.28 g) in acetonitrile (100 ml), and 2,6-pyridinedicarbonyldichloride (16) (4.08 g) was added. And stirred for 1 hour. 1N Hydrochloric acid (100 ml) was added and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (17) (10.0 g, 92%).

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0022[Name of item to be corrected] 0022

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0022】例5(化合物19の合成) 化合物(11)(8.28 g)のアセトニトリル(100 ml)溶液にピ
リジン(4 ml)を加え、アジピン酸クロライド(18)(3.66
g)を添加して1時間攪拌した。一規定塩酸(100 ml) を
加えて析出した結晶を濾取した。得られた結晶を水で洗
い乾燥して化合物(19)(9.9 g, 78%)を得た。
Example 5 (Synthesis of Compound 19) Pyridine (4 ml) was added to a solution of the compound (11) (8.28 g) in acetonitrile (100 ml), and adipic acid chloride (18) (3.66) was added.
g) was added and stirred for 1 hour. 1N hydrochloric acid (100 ml) was added, and the precipitated crystals were collected by filtration. The obtained crystals were washed with water and dried to obtain compound (19) (9.9 g, 78%).

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0027[Name of item to be corrected] 0027

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0027】例10(化合物5の合成) 化合物(15)(1.09 g)およびフェニルヒドラジン化合物(2
1)(0.75 g)をN,N-ジメチルアセトアミド(10 ml) 中に加
えて2時間加熱還流した。溶媒を溜去し、残査にイソプ
ロピルアルコール(50 ml) を加えて析出した結晶を濾取
した。得られた結晶をイソプロピルアルコールで洗浄し
て化合物(5) (0.26 g, 16%, m.p.>300℃) を得た。NMR
(δ ppm, CDCl3) 2.56(4H,d), 7.72(5H,m), 7.86(12H,
m), 8.18(2H,d), 8.59(1H,s), 10.54(2H,s)
Example 10 (Synthesis of Compound 5) Compound (15) (1.09 g) and phenylhydrazine compound (2
1) (0.75 g) was added to N, N-dimethylacetamide (10 ml), and the mixture was heated under reflux for 2 hours. The solvent was distilled off, isopropyl alcohol (50 ml) was added to the residue, and the precipitated crystals were collected by filtration. The obtained crystals were washed with isopropyl alcohol to give compound (5) (0.26 g, 16%, mp> 300 ° C). NMR
(δ ppm, CDCl 3 ) 2.56 (4H, d), 7.72 (5H, m), 7.86 (12H,
m), 8.18 (2H, d), 8.59 (1H, s), 10.54 (2H, s)

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 以下の式: 【化1】 (式中、X は炭素数 1〜6 の直鎖若しくは分岐鎖のメチ
レン基、置換若しくは無置換のフェニレン基、又は置換
若しくは無置換のピリジンジイル基を示し;R1はそれぞ
れ独立に水素原子又はハロゲン原子を示し;Y はそれぞ
れ独立に炭素数 1〜6 の直鎖若しくは分岐鎖のアルキル
基又は水酸基を示し;n 及び mはそれぞれ独立に1 又は
2 を示す)で示されるピラゾロン化合物。
1. The following formula: (In the formula, X represents a linear or branched methylene group having 1 to 6 carbon atoms, a substituted or unsubstituted phenylene group, or a substituted or unsubstituted pyridinediyl group; R 1 is independently a hydrogen atom or Represents a halogen atom; Y represents each independently a linear or branched alkyl group having 1 to 6 carbon atoms or a hydroxyl group; n and m each independently represent 1 or
A pyrazolone compound represented by 2).
【請求項2】 X が炭素数 3〜5 の直鎖のメチレン基、
無置換のフェニレン基、又は無置換のピリジンジイル基
であり;R1が独立に水素原子又はハロゲン原子であり;
Y が水酸基であり;n 及び mがそれぞれ独立に1 又は2
である請求項1に記載の化合物。
2. X is a straight-chain methylene group having 3 to 5 carbon atoms,
An unsubstituted phenylene group or an unsubstituted pyridinediyl group; R 1 is independently a hydrogen atom or a halogen atom;
Y is a hydroxyl group; n and m are each independently 1 or 2
The compound of claim 1, which is
【請求項3】 X が-(CH2)4-、無置換のm-若しくはp-フ
ェニレン基、又は無置換の2,6-ピリジンジイル基であ
り;-NHCO-X-CONH- 基が結合するフェニル基上に置換す
るピラゾロン-3- イル基が該フェニル環上で-NHCO-X-CO
NH- 基に対してm-またはp-置換であり;R1が独立に水素
原子又は塩素原子であり;Y が水酸基であり;n 及び m
がそれぞれ独立に1 又は2 である請求項2に記載の化合
物。
Wherein X is - (CH 2) 4 -, it is unsubstituted m- or p- phenylene, or unsubstituted 2,6-pyridine-diyl group; -NHCO-X-CONH- group is bonded A substituted pyrazolon-3-yl group on the phenyl group is -NHCO-X-CO
M- or p-substituted with respect to the NH- group; R 1 is independently a hydrogen atom or a chlorine atom; Y is a hydroxyl group; n and m
The compound according to claim 2, wherein each independently is 1 or 2.
【請求項4】 ピラゾロン-3- イル基が該フェニル環上
で-NHCO-X-CONH- 基に対してp-置換である請求項3に記
載の化合物。
4. The compound according to claim 3, wherein the pyrazolon-3-yl group is p-substituted on the phenyl ring with respect to the -NHCO-X-CONH- group.
JP7136413A 1995-06-02 1995-06-02 Pyrazolone compound Pending JPH08325470A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7136413A JPH08325470A (en) 1995-06-02 1995-06-02 Pyrazolone compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7136413A JPH08325470A (en) 1995-06-02 1995-06-02 Pyrazolone compound

Publications (1)

Publication Number Publication Date
JPH08325470A true JPH08325470A (en) 1996-12-10

Family

ID=15174587

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7136413A Pending JPH08325470A (en) 1995-06-02 1995-06-02 Pyrazolone compound

Country Status (1)

Country Link
JP (1) JPH08325470A (en)

Similar Documents

Publication Publication Date Title
RU2329252C1 (en) Method of obtaining derivatives of n-piperidino-1,5-diphenylpyrazole-3-carboxamide
BR112016021260B1 (en) 2- (2,4-DIFLUOROFENIL) -1,1-DIFLUORO-1- (5-REPLACED-PIRIDIN-2-IL) -3- (1H-TETRAZOL-1-IL) PROPAN-2-OIS AND PROCESSES FOR YOUR PREPARATION
RU2272036C2 (en) Method for preparing mesylate derivatives of piperazine
JPH08325470A (en) Pyrazolone compound
RU2288915C2 (en) Method for preparing racemic and pure enantiomers of derivatives of 1,5-diaryl-3-trifluoromethyl-2-pyrazolines
US2618641A (en) Arylidene-bis-pyrazolones
US4188489A (en) Process for the production of 3-substituted amino-5-pyrazolones
JP2005502604A5 (en) Process for the preparation of racemic and enantiomerically pure derivatives of 1,5-diaryl-3-trifluoromethyl-Δ2-pyrazoline
SU1331423A3 (en) Method of production of alkylenediamines or their pharmaceutically consistent salts
RU2373196C2 (en) Method of producing n-aminopiperidine and salts thereof
EP1204636A1 (en) 3-oxopropane-1-sulphonic acids and sulphonates
JPS5936630B2 (en) 2-imino-1,3-diazacycloalkane derivative
JPH01207276A (en) Novel propane derivative
JP2001098180A (en) Diaminostilbene derivative
JP2563231B2 (en) Method for synthesizing 1H-pyrazolo [1,5-b] -1,2,4-triazole derivative
JPS6146476B2 (en)
JPS62249976A (en) Manufacture of 1-aryl-5-aminopyrazole
JPH05287210A (en) Production of azomethine dye and indoaniline dye
JPS58145943A (en) Color coupler
JP2024041869A5 (en)
US5292951A (en) 1,3,4-oxadiazoles containing the pentafluorothio (SF5) group
JPH01287073A (en) Production of 5-amino-1h pyrazole compound
CA1187899A (en) Substituted n-aniline-4-chloro-3-sulphamoyl benzamides
JP5148188B2 (en) Barbituric acid compounds
JPH0477560A (en) Preparation of symmetric cyanine dyestuff